AIRLINK 181.90 Decreased By ▼ -0.24 (-0.13%)
BOP 11.68 Increased By ▲ 0.05 (0.43%)
CNERGY 8.09 Decreased By ▼ -0.12 (-1.46%)
FCCL 46.95 Decreased By ▼ -0.22 (-0.47%)
FFL 16.65 Increased By ▲ 0.48 (2.97%)
FLYNG 28.45 Decreased By ▼ -0.07 (-0.25%)
HUBC 142.35 Decreased By ▼ -0.87 (-0.61%)
HUMNL 13.31 Decreased By ▼ -0.10 (-0.75%)
KEL 4.57 Decreased By ▼ -0.05 (-1.08%)
KOSM 6.35 Increased By ▲ 0.19 (3.08%)
MLCF 59.55 Increased By ▲ 0.30 (0.51%)
OGDC 228.50 Increased By ▲ 1.69 (0.75%)
PACE 6.00 Decreased By ▼ -0.05 (-0.83%)
PAEL 47.90 Decreased By ▼ -0.33 (-0.68%)
PIAHCLA 18.40 Decreased By ▼ -0.99 (-5.11%)
PIBTL 10.62 Decreased By ▼ -0.10 (-0.93%)
POWER 11.62 Increased By ▲ 0.05 (0.43%)
PPL 192.30 Increased By ▲ 0.03 (0.02%)
PRL 39.04 Decreased By ▼ -0.09 (-0.23%)
PTC 24.40 Increased By ▲ 0.15 (0.62%)
SEARL 101.50 Decreased By ▼ -0.46 (-0.45%)
SILK 1.15 No Change ▼ 0.00 (0%)
SSGC 38.25 Increased By ▲ 0.52 (1.38%)
SYM 15.50 Decreased By ▼ -0.13 (-0.83%)
TELE 8.05 Decreased By ▼ -0.05 (-0.62%)
TPLP 11.15 Increased By ▲ 0.19 (1.73%)
TRG 68.99 Increased By ▲ 0.46 (0.67%)
WAVESAPP 11.30 Increased By ▲ 0.29 (2.63%)
WTL 1.42 No Change ▼ 0.00 (0%)
YOUW 3.91 Increased By ▲ 0.12 (3.17%)
AIRLINK 181.90 Decreased By ▼ -0.24 (-0.13%)
BOP 11.68 Increased By ▲ 0.05 (0.43%)
CNERGY 8.09 Decreased By ▼ -0.12 (-1.46%)
FCCL 46.95 Decreased By ▼ -0.22 (-0.47%)
FFL 16.65 Increased By ▲ 0.48 (2.97%)
FLYNG 28.45 Decreased By ▼ -0.07 (-0.25%)
HUBC 142.35 Decreased By ▼ -0.87 (-0.61%)
HUMNL 13.31 Decreased By ▼ -0.10 (-0.75%)
KEL 4.57 Decreased By ▼ -0.05 (-1.08%)
KOSM 6.35 Increased By ▲ 0.19 (3.08%)
MLCF 59.55 Increased By ▲ 0.30 (0.51%)
OGDC 228.50 Increased By ▲ 1.69 (0.75%)
PACE 6.00 Decreased By ▼ -0.05 (-0.83%)
PAEL 47.90 Decreased By ▼ -0.33 (-0.68%)
PIAHCLA 18.40 Decreased By ▼ -0.99 (-5.11%)
PIBTL 10.62 Decreased By ▼ -0.10 (-0.93%)
POWER 11.62 Increased By ▲ 0.05 (0.43%)
PPL 192.30 Increased By ▲ 0.03 (0.02%)
PRL 39.04 Decreased By ▼ -0.09 (-0.23%)
PTC 24.40 Increased By ▲ 0.15 (0.62%)
SEARL 101.50 Decreased By ▼ -0.46 (-0.45%)
SILK 1.15 No Change ▼ 0.00 (0%)
SSGC 38.25 Increased By ▲ 0.52 (1.38%)
SYM 15.50 Decreased By ▼ -0.13 (-0.83%)
TELE 8.05 Decreased By ▼ -0.05 (-0.62%)
TPLP 11.15 Increased By ▲ 0.19 (1.73%)
TRG 68.99 Increased By ▲ 0.46 (0.67%)
WAVESAPP 11.30 Increased By ▲ 0.29 (2.63%)
WTL 1.42 No Change ▼ 0.00 (0%)
YOUW 3.91 Increased By ▲ 0.12 (3.17%)
BR100 12,666 Increased By 34.7 (0.27%)
BR30 39,480 Increased By 35.9 (0.09%)
KSE100 118,909 Increased By 139 (0.12%)
KSE30 36,525 Decreased By -7.3 (-0.02%)
World

Australia administers first Covid-19 vaccines

  • The country's vaccination programme is starting months after other nations', following its provisional approval of the Pfizer product for use in January.
Published February 21, 2021

SYDNEY: Australia's Covid-19 vaccine rollout began Sunday, with top officials among a small group receiving the first jabs a day before the vaccination programme starts in earnest.

Prime Minister Scott Morrison was injected with the Pfizer/BioNTech vaccine at a medical centre in Sydney's northwest, in what the government said was an effort to boost public confidence in the vaccinations.

Jane Malysiak, an aged care resident and WWII survivor in her 80s, was the country's first person to receive the vaccine, followed by health care workers and other officials. "She's taking part in what is a very historic day for our country," Morrison said.

"Tomorrow our vaccination programme starts, so as a curtain-raiser today we're here making some very important points -- that it's safe, that it's important, and we need to start with those who are most vulnerable and are on the front line."

It comes a day after anti-vaccination demonstrations in major cities attracted thousands, with police arresting several protesters in Melbourne, according to public broadcaster ABC.

Almost 22 percent of Australians said they were unlikely to get the jab, with vaccine hesitancy rising in recent months, an Australian National University survey found.

The country's vaccination programme is starting months after other nations', following its provisional approval of the Pfizer product for use in January.

The Oxford/AstraZeneca vaccine was also approved in recent days but is yet to be administered.

Australia has been relatively successful in containing the virus to date, with almost 29,000 cases and 909 deaths in a population of 25 million.

Comments

Comments are closed.